EE200300413A - Taksaani metronoomiline annustamisskeem ning meetod kasvajarakkude kasvu pärssimiseks - Google Patents

Taksaani metronoomiline annustamisskeem ning meetod kasvajarakkude kasvu pärssimiseks

Info

Publication number
EE200300413A
EE200300413A EEP200300413A EEP200300413A EE200300413A EE 200300413 A EE200300413 A EE 200300413A EE P200300413 A EEP200300413 A EE P200300413A EE P200300413 A EEP200300413 A EE P200300413A EE 200300413 A EE200300413 A EE 200300413A
Authority
EE
Estonia
Prior art keywords
taxane
cell growth
tumor cell
dosing regimen
inhibiting tumor
Prior art date
Application number
EEP200300413A
Other languages
English (en)
Estonian (et)
Inventor
Fargnoli Joseph
C. Rose William
Trail Pamela
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of EE200300413A publication Critical patent/EE200300413A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Carpets (AREA)
EEP200300413A 2001-02-28 2002-02-26 Taksaani metronoomiline annustamisskeem ning meetod kasvajarakkude kasvu pärssimiseks EE200300413A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27194401P 2001-02-28 2001-02-28
PCT/US2002/005971 WO2002067928A2 (en) 2001-02-28 2002-02-26 Metronomic dosing of taxanes for inhibiting tumor growth

Publications (1)

Publication Number Publication Date
EE200300413A true EE200300413A (et) 2003-12-15

Family

ID=23037749

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300413A EE200300413A (et) 2001-02-28 2002-02-26 Taksaani metronoomiline annustamisskeem ning meetod kasvajarakkude kasvu pärssimiseks

Country Status (31)

Country Link
EP (1) EP1372636B1 (cs)
JP (1) JP2004538253A (cs)
KR (1) KR20030086276A (cs)
CN (1) CN1533273A (cs)
AR (1) AR033609A1 (cs)
AT (1) ATE331511T1 (cs)
BG (1) BG108167A (cs)
BR (1) BR0207519A (cs)
CA (1) CA2439299A1 (cs)
CY (1) CY1105468T1 (cs)
CZ (1) CZ20032232A3 (cs)
DE (2) DE02723255T1 (cs)
DK (1) DK1372636T3 (cs)
EE (1) EE200300413A (cs)
ES (1) ES2211374T3 (cs)
HR (1) HRP20030775A2 (cs)
HU (1) HUP0402115A2 (cs)
IL (1) IL157356A0 (cs)
IS (1) IS6924A (cs)
MX (1) MXPA03007655A (cs)
NO (1) NO20033809L (cs)
PE (1) PE20020955A1 (cs)
PL (1) PL373376A1 (cs)
PT (1) PT1372636E (cs)
RU (1) RU2003129233A (cs)
SK (1) SK10332003A3 (cs)
TR (1) TR200400375T3 (cs)
UY (1) UY27185A1 (cs)
WO (1) WO2002067928A2 (cs)
YU (1) YU66603A (cs)
ZA (1) ZA200306450B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
EP2286794B8 (en) * 2003-10-15 2016-06-01 SynCore Biotechnology CO., LTD Use of cationic liposomes comprising paclitaxel
US9233094B2 (en) 2005-05-04 2016-01-12 Medigene Ag Method of administering a cationic liposomal preparation
AU2007228984B2 (en) 2006-03-22 2012-05-03 Syncore Biotechnology Co., Ltd Treatment of triple receptor negative breast cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998053811A1 (en) * 1997-05-27 1998-12-03 Baker Norton Pharmaceuticals, Inc. Method and compositions for administering taxanes orally to human patients
US6750246B1 (en) * 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US6362217B2 (en) * 2000-03-17 2002-03-26 Bristol-Myers Squibb Company Taxane anticancer agents

Also Published As

Publication number Publication date
DE60212813D1 (de) 2006-08-10
ES2211374T3 (es) 2007-03-01
JP2004538253A (ja) 2004-12-24
PL373376A1 (en) 2005-08-22
ES2211374T1 (es) 2004-07-16
TR200400375T3 (tr) 2004-04-21
HUP0402115A2 (hu) 2005-02-28
NO20033809D0 (no) 2003-08-27
CN1533273A (zh) 2004-09-29
CA2439299A1 (en) 2002-09-06
WO2002067928A2 (en) 2002-09-06
EP1372636A2 (en) 2004-01-02
AR033609A1 (es) 2003-12-26
BR0207519A (pt) 2005-03-08
SK10332003A3 (sk) 2005-03-04
DK1372636T3 (da) 2006-11-06
CZ20032232A3 (en) 2004-06-16
RU2003129233A (ru) 2005-02-10
WO2002067928A3 (en) 2003-10-09
BG108167A (en) 2004-09-30
HRP20030775A2 (en) 2005-02-28
EP1372636B1 (en) 2006-06-28
PE20020955A1 (es) 2002-10-30
YU66603A (sh) 2006-08-17
ZA200306450B (en) 2004-11-19
MXPA03007655A (es) 2003-12-04
DE60212813T2 (de) 2007-01-18
IL157356A0 (en) 2004-02-19
UY27185A1 (es) 2002-09-30
DE02723255T1 (de) 2004-07-15
ATE331511T1 (de) 2006-07-15
CY1105468T1 (el) 2010-04-28
NO20033809L (no) 2003-10-23
KR20030086276A (ko) 2003-11-07
PT1372636E (pt) 2006-09-29
IS6924A (is) 2003-08-22

Similar Documents

Publication Publication Date Title
EP1460414A4 (en) CONCENTRATION MEASURING METHOD
DE60217458D1 (de) Massenspektrometer und Verfahren
DE60133303D1 (de) Halbleitergrundmaterial und verfahren zu seiner herstellung
AU2003268536A8 (en) Wireless game device and method for using the same
EP1408562A4 (en) MAGNETIC SENSOR AND METHOD FOR MANUFACTURING SAME
ITBO20020487A0 (it) Contenitore e metodo per la realizzazione dello stesso
DE602004013131D1 (de) Spielautomat, spielmethode und programm
DE602004020085D1 (de) Radium-target und herstellungsverfahren dafür
GB0220553D0 (en) Method andapparatus for determining the viability of eggs
FI20020092A7 (fi) Soitinmuunnin ja menetelmä sen valmistamiseksi
DE60230823D1 (de) L-cystein herstellendes Bakterium und Verfahren zur Herstellung von L-cystein
NO20024880D0 (no) Sammensetning inneholdende fosfat
GB0509662D0 (en) 3-5 group compound semiconductor and method for preparation thereof
ZA200306450B (en) Metronomic dosing of taxanes.
EP1322322A4 (en) COMPOUNDS AND METHODS FOR INHIBITING INTEGRINS ALPHA-1 BETA-1
FI20041495L (fi) Liukastussuojattu peite sekä menetelmä sen valmistamiseksi
AU2003297181A8 (en) Compositions and methods for inhibiting tumor growth and metastasis
SI1372636T1 (sl) Metronomsko odmerjanje taksanov za inhibiranje tumorske rasti
GB0303005D0 (en) Method of radio-labelling biomolecules
FI5678U1 (fi) Kantopakkaus ja kantoelin
ITMI20020303V0 (it) Confezione per pubblicazioni editoriali giochi e simili
SE0201603D0 (sv) Player meter
EP1597236A4 (en) METHOD OF STIMULATING GROWTH
SE0202220L (sv) Infusion container and method for producing the same
PL351692A1 (en) Method of validating measurements